IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Nature Reviews Cancer

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

37.34

h-Index

2022-2023

 484

Rank

2022-2023

 11

SJR

2022-2023

 20.977

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Nature Reviews Cancer
Abbreviation Nat. Rev. Cancer
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q1); Oncology (Q1)
h-index 484
Overall Rank/Ranking 11
SCImago Journal Rank (SJR) 20.977
Impact Score 37.34
Publisher Nature Publishing Group
Country United Kingdom
ISSN 1474175X, 14741768
Best Quartile Q1
Coverage History 2001-2022




Aim and Scope


The ultimate aim of cancer research is to eliminate this common and devastating disease from the human population. To develop more effective prevention methods we need to understand what triggers carcinogenesis. To diagnose precancerous lesions and early-stage cancers quickly and accurately we need to detect the earliest molecular changes leading to each type of cancer. To determine a patient"s prognosis we need to appreciate which molecular changes affect tumour growth rate and invasiveness. And to tailor therapies to individual tumours we need to understand the fundamental differences, not only between a cancer cell and a "normal" cell, but also between one cancer cell and another. All of these goals depend on a combination of basic and applied research.


About Nature Reviews Cancer


Nature Reviews Cancer is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Oncology (Q1). It is published by Nature Publishing Group. The overall rank of Nature Reviews Cancer is 11. According to SCImago Journal Rank (SJR), this journal is ranked 20.977. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 484. The best quartile for this journal is Q1.

The ISSN of Nature Reviews Cancer journal is 1474175X, 14741768. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Nature Reviews Cancer is cited by a total of 10528 articles during the last 3 years (Preceding 2022).


Nature Reviews Cancer Impact IF 2022-2023


The Impact IF 2022 of Nature Reviews Cancer is 37.34, which is computed in 2023 as per its definition. Nature Reviews Cancer IF is increased by a factor of 9.88 and approximate percentage change is 35.98% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Nature Reviews Cancer Impact IF 2023 Prediction


Impact IF 2022 of Nature Reviews Cancer is 37.34. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of Nature Reviews Cancer. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 37.34
2021 27.46
2020 18.41
2019 22.11
2018 25.38
2017 21.47
2016 16.71
2015 15.64
2014 16.71

Nature Reviews Cancer h-index


  Table Setting

Nature Reviews Cancer has an h-index of 484. It means 484 articles of this journal have more than 484 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Nature Reviews Cancer ISSN


The ISSN of Nature Reviews Cancer is 1474175X, 14741768. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Nature Reviews Cancer Rank and SCImago Journal Rank (SJR)


The overall rank of Nature Reviews Cancer is 11. According to SCImago Journal Rank (SJR), this journal is ranked 20.977. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Nature Reviews Cancer by Year


Year SJR
2023/2024 Coming Soon
2022 20.977
2021 16.955
2020 19.575
2019 21.287
2018 28.061
2017 23.530
2016 22.315
2015 25.056
2014 24.923

Ranking of Nature Reviews Cancer by Year


Year Ranking
2023/2024 Coming Soon
2022 11
2021 21
2020 16
2019 10
2018 7
2017 11
2016 10
2015 9
2014 9

Nature Reviews Cancer Publisher


Table Setting

Nature Reviews Cancer is published by Nature Publishing Group. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2001-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Nature Reviews Cancer is Nat. Rev. Cancer. This abbreviation ('Nat. Rev. Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Nature Reviews Cancer


If your research field is/are related to Cancer Research (Q1); Oncology (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Nature Reviews Cancer?

Nature Reviews Cancer latest impact IF is 37.34. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 37.34 (2022) and 15.64 (2015), respectively, in the last 9 years. Moreover, its average IS is 22.36 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Nature Reviews Cancer?

The Nature Reviews Cancer has an SJR (SCImago Journal Rank) of 20.977, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 28.061 in 2018 and the lowest being 16.955 in 2021. Furthermore, the average SJR of the Nature Reviews Cancer over the previous 9-year period stands at 22.36.


What's the latest h-index of the Nature Reviews Cancer?

The latest h-index of the Nature Reviews Cancer is 484.


Who's the publisher of the Nature Reviews Cancer?

The Nature Reviews Cancer is published by the Nature Publishing Group, with its country of publication being the United Kingdom.


What's the current ranking of the Nature Reviews Cancer?

The Nature Reviews Cancer is currently ranked 11 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 7 in 2018 and its lowest position of 21 in 2021.


What's the abbreviation or short name for the Nature Reviews Cancer?

The standard ISO4 abbreviation for the Nature Reviews Cancer is Nat. Rev. Cancer.


Is the "Nature Reviews Cancer" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Nature Reviews Cancer is classified as a journal that the Nature Publishing Group publishes.


What's the scope or major areas of the Nature Reviews Cancer?

The Nature Reviews Cancer encompasses the following areas:

  • Cancer Research
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Nature Reviews Cancer?

The Nature Reviews Cancer is assigned the following International Standard Serial Numbers (ISSN): 1474175X, 14741768.


What's the best quartile of the Nature Reviews Cancer?

The best quartile for the Nature Reviews Cancer is Q1 (2022).


What's the coverage history of the Nature Reviews Cancer?

The Nature Reviews Cancer coverage history can be summarized as follows: 2001-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Economics and Management journal 10343 Vilnius Gediminas Technical University 45 2.81
Dermatologia Kliniczna journal 25442 Cornetis 7 0.00
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division conference and proceedings 17477 16 0.00
International Journal of Mathematical Education in Science and Technology journal 10040 Taylor and Francis Ltd. 39 1.33
Materials Research journal 14791 Universidade Federal de Sao Carlos 65 1.62
International Journal of Applied Linguistics journal 7321 Wiley-Blackwell Publishing Ltd 51 2.00
British Journal of Special Education journal 12024 Wiley-Blackwell Publishing Ltd 42 1.24
Socialism and Democracy journal 26162 Taylor and Francis Ltd. 17 0.09
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS conference and proceedings 781 Association for Computing Machinery (ACM) 100 8.01
Proceedings of the Technical Association of the Graphic Arts, TAGA conference and proceedings 30903 Technical Association of the Graphic 8 0.00

Check complete list




Year wise Impact Score (IS) of Nature Reviews Cancer

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 37.34
2021 27.46
2020 18.41
2019 22.11
2018 25.38
2017 21.47
2016 16.71
2015 15.64
2014 16.71



Top Journals/Conferences in Cancer Research

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

See All